Evvy raised a $40 million Series B for vaginal microbiome testing data. CEO Priyanka Jain explains why the genomes stay private and who ends up owning them.
The US startup Evvy raised USD 40 million to expand its platform for analysis of vaginal microbiome, develop fertility research, and incorporate artificial intelligence into the care of its patients.